Nā huahana
-
MTHFR Gene Polymorphic Nucleic Acid
Hoʻohana ʻia kēia pahu no ka ʻike ʻana i nā pae hoʻololi ʻelua o ka gene MTHFR. Hoʻohana ka pahu i ke koko holoʻokoʻa o ke kanaka ma ke ʻano he laʻana hoʻāʻo e hāʻawi i kahi loiloi qualitative o ke kūlana mutation. Hiki iā ia ke kōkua i nā kauka e hoʻolālā i nā hoʻolālā lapaʻau kūpono no nā ʻano like ʻole o kēlā me kēia kanaka mai ka pae molekala, i mea e hōʻoia ai i ke olakino o nā maʻi i ka nui loa.
-
Hoʻololi kanaka BRAF Gene V600E
Hoʻohana ʻia kēia pahu hoʻāʻo e ʻike pono i ka hoʻololi ʻana o ka BRAF gene V600E i loko o nā ʻano kikoo paraffin-embedded o ka melanoma kanaka, colorectal cancer, thyroid cancer and lung cancer in vitro.
-
ʻO ke kanaka BCR-ABL Fusion Gene Mutation
He kūpono kēia pahu no ka ʻike qualitative o p190, p210 a me p230 isoforms o ka BCR-ABL fusion gene i loko o nā laʻana o ka iwi iwi kanaka.
-
KRAS 8 Hoololi
Kuhi ʻia kēia pahu no ka ʻike in vitro qualitative o 8 mau hoʻololi i nā codons 12 a me 13 o K-ras gene i loko o ka DNA i unuhi ʻia mai nā ʻāpana pathological i hoʻopili ʻia e ke kanaka.
-
Kanaka EGFR Gene 29 Mutations
Hoʻohana ʻia kēia kit no ka ʻike in vitro qualitatively o nā mutation maʻamau i nā exons 18-21 o ka gene EGFR i nā laʻana mai nā maʻi maʻi maʻi maʻi maʻi ʻaʻole liʻiliʻi liʻiliʻi.
-
ʻO ke kanaka ROS1 Fusion Gene Mutation
Hoʻohana ʻia kēia pahu i ka ʻike in vitro qualitative o 14 ʻano o ka ROS1 fusion gene mutations i loko o nā ʻano maʻi maʻi maʻi ʻaʻai liʻiliʻi liʻiliʻi liʻiliʻi (Papa 1). ʻO nā hopena hōʻike no ka hōʻike lapaʻau wale nō a ʻaʻole pono e hoʻohana ʻia ma ke kumu hoʻokahi no ka mālama ʻana i nā maʻi.
-
ʻO ke kanaka EML4-ALK Fusion Gene Mutation
Hoʻohana ʻia kēia kit e ʻike pono i nā ʻano mutation 12 o EML4-ALK fusion gene i nā laʻana o nā mea maʻi maʻi maʻi maʻi maʻi ʻaʻai liʻiliʻi liʻiliʻi i vitro. ʻO nā hopena hōʻike no ka hōʻike lapaʻau wale nō a ʻaʻole pono e hoʻohana ʻia ma ke kumu hoʻokahi no ka mālama ʻana i nā maʻi. Pono nā kauka lapaʻau e hoʻoholo i nā hopena hōʻike ma muli o nā kumu e like me ke kūlana o ka mea maʻi, nā hōʻailona lāʻau, ka pane ʻana i ka lāʻau, a me nā hōʻailona hōʻike hoʻokolohua ʻē aʻe.
-
Mycoplasma Hominis Nucleic Acid
He mea kūpono kēia kit no ka ʻike qualitative o Mycoplasma hominis (MH) i loko o ka ʻāpana mimi kāne a me nā ʻāpana huna huna wahine.
-
Herpes Simplex Virus Type 1/2，(HSV1/2) Nucleic Acid
Hoʻohana ʻia kēia pahu no ka ʻike in vitro qualitative o Herpes Simplex Virus Type 1 (HSV1) a me Herpes Simplex Virus Type 2 (HSV2) e kōkua i ka hoʻomaʻamaʻa a mālama ʻana i nā poʻe maʻi i manaʻo ʻia he maʻi HSV.
-
ʻO SARS-CoV-2 Virus Antigen - Hōʻike home
ʻO kēia pahu Detection no ka in vitro qualitative detection of SARS-CoV-2 antigen i nā laʻana swab nasal. Kuhi ʻia kēia hoʻāʻo no ka hoʻohana ʻana i ka home no ka hoʻāʻo ponoʻī ʻana me nā laʻana swab mua o ka ihu (nares) i hōʻiliʻili ponoʻī ʻia mai nā poʻe he 15 mau makahiki a ʻoi aku paha ka poʻe i manaʻo ʻia he COVID-19 a i ʻole nā mea makua i hōʻiliʻili i nā laʻana nasal swab mai nā poʻe ma lalo o 15 mau makahiki i manaʻo ʻia he COVID-19.
-
ʻO ka ʻakika Nucleic Acid
He kūpono kēia kit no ka ʻike qualitative o Yellow Fever virus nucleic acid i nā serum samples o nā maʻi, a hāʻawi i kahi ala kōkua kūpono no ka maʻi maʻi a me ka mālama ʻana i ka maʻi maʻi Yellow Fever. ʻO nā hopena hoʻāʻo no ka hōʻike lapaʻau wale nō, a pono e noʻonoʻo ʻia ka ʻike hope loa me ka hui pū ʻana me nā hōʻailona lapaʻau ʻē aʻe.
-
HIV Ka nui
Hoʻohana ʻia ʻo HIV Quantitative Detection Kit (Fluorescence PCR) (ma hope aʻe nei ʻo ka kit) no ka ʻike nui ʻana o ka maʻi maʻi immunodeficiency kanaka (HIV) RNA i loko o ka serum kanaka a i ʻole nā laʻana plasma.
